Metarrestin
Metarrestin (ML246) is a first-in-class small molecule inhibitor that targets the perinucleolar compartment, disrupting nucleolar structure and suppressing RNA Pol I transcription via interaction with eEF1A2. It demonstrates a favorable pharmacokinetic profile and has been shown to effectively inhibit metastatic progression in both in vitro and in vivo cancer models.
Product Specifications
CAS Number
1443414-10-5
Product Name Alternative
Compartment, breast, DNA/RNA Synthesis, DNA Synthesis, DNASynthesis, pancreatic, PANC1, PC3M, Metarrestin, metastatic, nucleolar, orally, ML246, ML-246, ML 246, inhibit, eEF1A2, Inhibitor, HeLa, perinucleolar, RNASynthesis, RNA polymerase (Pol) I, RNA polymerase I, RNA Synthesis, transcription
Field of Research
Cell Biology, Molecular Biology
Purity
99.04% (May vary between batches)
Solubility
DMSO:4.75 mg/mL (10.01 mM)
Smiles
O[C@H]1CC[C@@H] (CC1) n1cnc2n (Cc3ccccc3) c (c (-c3ccccc3) c2c1=N) -c1ccccc1
Molecular Formula
C31H30N4O
Molecular Weight
474.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6449195-01 0.1 mL
SARS (Severe Acute Respiratory Syndrome, SERS, SERRS) (MaxLight 650)
Sign In for Pricing
View Details